Mestinon

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
Revision as of 15:48, September 14, 2017 by Kmdenmark (talk | contribs) (added blog post)

Mestinon (Pyridostigmine) is an aceytlcholinesterase inhibitor used to treat myasthenia gravis. It inhibits the acetylcholinesterase enzyme from breaking down acetylcholine, resulting in higher circulating levels of the neurotransmitter.

Anecdotally, some ME/CFS patients have derived huge benefits from Mestinon, others none at all.[1]

Learn more[edit | edit source]

References[edit | edit source]